Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
976 GBX | +0.10% | +2.52% | -42.01% |
Apr. 24 | Jefferies Cuts CVS Group PT, Maintains at Hold | MT |
Apr. 24 | Investec cuts Hipgnosis Songs Fund to 'hold' | AN |
Strengths
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- The company is not the most generous with respect to shareholders' compensation.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-42.01% | 872M | B | ||
-33.57% | 130M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- CVSG Stock
- Ratings CVS Group plc